MedPath

Effects of esomeprazole on symptoms indicative of gastroesophageal reflux disease observed in patients taking non-steroidal anti-inflammatory drugs (NSAIDs)

Not Applicable
Completed
Conditions
Patients who scored more than 8 on F scale questionnaire after taking NSAIDs more than 4 weeks are enrolled.
Registration Number
JPRN-jRCT1091220218
Lead Sponsor
Department of Orthopedic surgery, graduate school of medicine, Chiba University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria

Patients who scored more than 8 on F scale questionnaire after taking NSAIDs more than 4 weeks are enrolled.

Exclusion Criteria

1 Those who have bleedings from gastrointestinal system, sudden decrease of body weight
2 Those who have organic brain damage, schizophrenia
3 Alcohol dependency, drug abuse
4 Hormonal disorders such as hyperthyroidism
5 Severe renal or liver dysfunction, hematopoietic disorders
6 Those who take more than two anti-coagulants
7 Those who are allergic to drugs to be tested
8 Those who are pregnant or who wish to be pregnant during corresponding clinical test
9 Patients who are not regarded as improper by physician in charge

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
FSSG scale
Secondary Outcome Measures
NameTimeMethod
Subscores of FSSG scale
© Copyright 2025. All Rights Reserved by MedPath